NewsRx

Search our medical news database

Cancer Gene Therapy

President and CEO Nicholas Nicolaides Honored as Top 20 Scientist by R&D Directions

Published in Drug Law Weekly, April 3rd, 2007

As a child, Nicholas Nicolaides dreamed of working in cancer research. Since then, he has maintained a strong passion for science and medicine, always believing that cancer is one of the last frontiers of medicine and offers a unique opportunity to understand the molecular basis of human disease. His goal was to discover new pathways to determine how to pinpoint and effectively treat the disease. His mothers's death from cancer when he was 21 drove him even more passionately toward this objective.

Dr. Nicolaides is one of the foremost molecular geneticists in the United States, authoring more than 50 scientific papers on the molecular and genetic basis of cancer and...

Want to see the full article?

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Buy Now


Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Drug Law Weekly


NewsRx is Social

Follow us on your favorite social network by clicking on a button below:

Follow NewsRx on Twitter

NewsRx on Facebook

Awards

eHealthcare Leadership 2011 Winner
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

  • Google 2010 PageRank: #2 Among Top Health News and Media Publications
  • Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
  • Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
  • Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
NewsRx on Facebook